These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19882638)

  • 21. Myotonic discharges discriminate chloride from sodium muscle channelopathies.
    Drost G; Stunnenberg BC; Trip J; Borm G; McGill KC; Ginjaar IH; van der Kooi AW; Zwarts MJ; van Engelen BG; Faber CG; Stegeman DF; Lateva Z
    Neuromuscul Disord; 2015 Jan; 25(1):73-80. PubMed ID: 25454733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The electrophysiologic diagnosis for muscle ion channelopathies].
    Arimura Y; Nakamura T; Yoshimura M; Uehara A; Arimura K; Sakoda S; Takashima H
    Rinsho Shinkeigaku; 2012; 52(11):1252-5. PubMed ID: 23196580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel.
    McClatchey AI; McKenna-Yasek D; Cros D; Worthen HG; Kuncl RW; DeSilva SM; Cornblath DR; Gusella JF; Brown RH
    Nat Genet; 1992 Oct; 2(2):148-52. PubMed ID: 1338909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.
    Tan SV; Matthews E; Barber M; Burge JA; Rajakulendran S; Fialho D; Sud R; Haworth A; Koltzenburg M; Hanna MG
    Ann Neurol; 2011 Feb; 69(2):328-40. PubMed ID: 21387378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel CLCN1 mutation (G1652A) causing a mild phenotype of thomsen disease.
    Kumar KR; Ng K; Vandebona H; Davis MR; Sue CM
    Muscle Nerve; 2010 Mar; 41(3):412-5. PubMed ID: 20120005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype.
    Dunø M; Colding-Jørgensen E; Grunnet M; Jespersen T; Vissing J; Schwartz M
    Eur J Hum Genet; 2004 Sep; 12(9):738-43. PubMed ID: 15162127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis.
    Pagliarani S; Meola G; Filareti M; Comi GP; Lucchiari S
    Front Neurol; 2022; 13():845383. PubMed ID: 36081873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II.
    Waguespack SG; Koller DL; White KE; Fishburn T; Carn G; Buckwalter KA; Johnson M; Kocisko M; Evans WE; Foroud T; Econs MJ
    J Bone Miner Res; 2003 Aug; 18(8):1513-8. PubMed ID: 12929941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of two new dominant ClC-1 channel mutations associated with myotonia.
    Grunnet M; Jespersen T; Colding-Jørgensen E; Schwartz M; Klaerke DA; Vissing J; Olesen SP; Dunø M
    Muscle Nerve; 2003 Dec; 28(6):722-32. PubMed ID: 14639587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of SCN4A gene variation in a Chinese pedigree affected with skeletal muscle sodium channelopathies].
    Lu Y; Yang X; Wang X; Xue P; Zhang J; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):809-812. PubMed ID: 31400134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A missense mutation in the skeletal muscle chloride channel 1 (CLCN1) as candidate causal mutation for congenital myotonia in a New Forest pony.
    Wijnberg ID; Owczarek-Lipska M; Sacchetto R; Mascarello F; Pascoli F; Grünberg W; van der Kolk JH; Drögemüller C
    Neuromuscul Disord; 2012 Apr; 22(4):361-7. PubMed ID: 22197188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular and genetic aspects of the myotonic conditions].
    Morales Montero F; Cuenca Berger P
    Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype.
    Waxman SG
    Nat Neurosci; 2007 Apr; 10(4):405-9. PubMed ID: 17387329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.
    Trip J; Drost G; Verbove DJ; van der Kooi AJ; Kuks JB; Notermans NC; Verschuuren JJ; de Visser M; van Engelen BG; Faber CG; Ginjaar IB
    Eur J Hum Genet; 2008 Aug; 16(8):921-9. PubMed ID: 18337730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene.
    Ebers GC; George AL; Barchi RL; Ting-Passador SS; Kallen RG; Lathrop GM; Beckmann JS; Hahn AF; Brown WF; Campbell RD
    Ann Neurol; 1991 Dec; 30(6):810-6. PubMed ID: 1686388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ion channel diseases in neurology].
    Lerche H; Mitrovic N; Lehmann-Horn F
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11):481-8. PubMed ID: 9480290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic variability in myotonia congenita.
    Colding-Jørgensen E
    Muscle Nerve; 2005 Jul; 32(1):19-34. PubMed ID: 15786415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel chloride channel mutations leading to mild myotonia among Chinese.
    Burgunder JM; Huifang S; Beguin P; Baur R; Eng CS; Seet RC; Lim EC; Ong BK; Hunziker W; Sigel E
    Neuromuscul Disord; 2008 Aug; 18(8):633-40. PubMed ID: 18579381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Periodic paralysis: new pathophysiological aspects].
    Fontaine B
    Bull Acad Natl Med; 2008 Nov; 192(8):1543-8; discussion 1549-50. PubMed ID: 19445371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.